SUVN-502
- Generic Name
- SUVN-502
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H24BrN3O3S
- CAS Number
- 701205-60-9
- Unique Ingredient Identifier
- 8XZ281AO3G
- Background
SUVN-502 is a novel, potent, safe, highly selective and orally active antagonist at a central nervous system serotonin receptor site 5-HT6 intended for treatment of cognitive disorders such as Alzheimer’s and Schizophrenia, an unmet medical need.
- Indication
Investigated for use/treatment in neurologic disorders.
- Associated Conditions
- -
- Associated Therapies
- -
Suven Life Sciences Ltd Summary
Suven Life Sciences, established in 1989, specializes in CNS therapies and CRAMS. It transitioned from contract research to collaborative research, focusing on neurodegenerative disorders. With a robust pipeline of 14 molecules, it has made significant strides in drug discovery, including CNS-based programs and clinical trials for novel therapeutics.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath